Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Clin Immunol. 2012 Aug;8(6):579-85.

Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?

Author information

1
Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, via Giustiniani 2, Padua, Italy.

Abstract

The identification of noninvasive biomarkers is still one of the major issue for gastroenterologists dealing with inflammatory bowel disease patients, due to the chronicity of these conditions and the early onset of symptoms in the majority of cases. Research attention has focused mainly on fecal proteins, especially calprotectin and lactoferrin, and most of the published data are reassuring about their applicability in the diagnosis and monitoring of these patients. However, there are still pending questions regarding the reliability of fecal proteins especially in the era of mucosal healing and biologics.

PMID:
22992152
DOI:
10.1586/eci.12.50
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center